ArticleFrontiers in public health2026
Trends and cross-country inequalities in the global burden of subarachnoid hemorrhage, 1990-2021: a population-based study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to analyze global and regional trends in the burden of subarachnoid hemorrhage (SAH) from 1990 to 2021, focusing on incidence, prevalence, disability-adjusted life years (DALYs), and mortality, and to examine socioeconomic inequalities across 204 countries and territories using Global Burden of Disease (GBD) data. Methods: Utilizing GBD 2021 data, we assessed SAH burden by incidence, prevalence, DALYs, and mortality, stratified by Socio-Demographic Index (SDI), sex, and region. Age-standardized rates were calculated to ensure comparability. Socioeconomic inequalities were evaluated using the Slope Index of Inequality (SII) and Concentration Index (CII). Spearman correlation analyses explored associations between SAH burden and SDI. Results: From 1990 to 2021, global SAH incident cases increased from 508,789 (95% UI 441,504-587,616) to 697,486 (95% UI 614,334-795,785), and prevalent cases rose from 4.90 million (95% UI 4.42-5.39 million) to 7.85 million (95% UI 7.16-8.58 million). Age-standardized incidence, prevalence, DALY, and mortality rates declined significantly, from 11.69 to 8.33, 109.90 to 92.17, 275.85 to 125.20, and 9.54 to 4.18 per 100,000, respectively. East Asia showed the largest declines (e.g., incidence from 17.74 to 7.89 per 100,000), while Andean Latin America had the highest burden (2021 prevalence: 172.03 per 100,000). Females had higher incidence and prevalence but lower DALYs and mortality. Middle SDI regions exhibited the largest case increases and rate declines. Socioeconomic inequalities worsened, with 2021 DALY SII at -47.27 (95% CI -71.58, -22.97) and mortality SII at -1.33 (95% CI -2.14, -0.51), indicating a shift in burden toward lower-income groups. SAH burden showed weak negative correlations with SDI, stronger for DALYs ( Conclusion: Despite increasing absolute SAH cases due to population growth and aging, age-standardized rates declined, reflecting improved risk factor management and healthcare. However, persistent regional disparities and growing socioeconomic inequalities, with heavier burdens in low SDI regions and lower-income groups, underscore the need for targeted interventions, enhanced healthcare access, and further research into region-specific risk factors to reduce the global SAH burden and address health inequities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.